Which is a subcutaneous dosing option for tocilizumab?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Which is a subcutaneous dosing option for tocilizumab?

Explanation:
Tocilizumab can be given either by IV infusion or as a subcutaneous injection. The subcutaneous option uses a fixed 162 mg dose every other week, which is a practical and commonly used self-administered regimen. Intravenous dosing is weight-based (4–8 mg/kg) every 4 weeks and must be given in a clinic. There is no oral form, and a daily 200 mg subcutaneous schedule is not part of its standard regimens. So the subcutaneous option that fits typical practice is 162 mg every other week.

Tocilizumab can be given either by IV infusion or as a subcutaneous injection. The subcutaneous option uses a fixed 162 mg dose every other week, which is a practical and commonly used self-administered regimen. Intravenous dosing is weight-based (4–8 mg/kg) every 4 weeks and must be given in a clinic. There is no oral form, and a daily 200 mg subcutaneous schedule is not part of its standard regimens. So the subcutaneous option that fits typical practice is 162 mg every other week.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy